{"id":"https://openalex.org/W2750718596","doi":"https://doi.org/10.1186/s12872-017-0672-5","title":"Comparative effectiveness of rivaroxaban versus warfarin or dabigatran for the treatment of patients with non-valvular atrial fibrillation","display_name":"Comparative effectiveness of rivaroxaban versus warfarin or dabigatran for the treatment of patients with non-valvular atrial fibrillation","publication_year":2017,"publication_date":"2017-09-06","ids":{"openalex":"https://openalex.org/W2750718596","doi":"https://doi.org/10.1186/s12872-017-0672-5","mag":"2750718596","pmid":"https://pubmed.ncbi.nlm.nih.gov/28874129","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5585896"},"language":"en","primary_location":{"id":"doi:10.1186/s12872-017-0672-5","doi":"https://doi.org/10.1186/s12872-017-0672-5","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12872-017-0672-5","pdf_url":"https://bmccardiovascdisord.biomedcentral.com/track/pdf/10.1186/s12872-017-0672-5","source":{"id":"https://openalex.org/S206686666","display_name":"BMC Cardiovascular Disorders","issn_l":"1471-2261","issn":["1471-2261"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Cardiovascular Disorders","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://bmccardiovascdisord.biomedcentral.com/track/pdf/10.1186/s12872-017-0672-5","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071468650","display_name":"Faye L. Norby","orcid":"https://orcid.org/0000-0002-1975-0405","observed_orcids":["https://orcid.org/0000-0002-1975-0405"]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Faye L. Norby","raw_affiliation_strings":["Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, 1300 S 2nd St, Suite 300, Minneapolis, MN, 55454, USA. flopez@umn.edu","Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, 1300 S 2nd St, Suite 300, Minneapolis, MN, 55454, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, 1300 S 2nd St, Suite 300, Minneapolis, MN, 55454, USA. flopez@umn.edu","institution_ids":["https://openalex.org/I130238516"]},{"raw_affiliation_string":"Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, 1300 S 2nd St, Suite 300, Minneapolis, MN, 55454, USA","institution_ids":["https://openalex.org/I130238516"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086138953","display_name":"Lindsay G.S. Bengtson","orcid":"https://orcid.org/0000-0002-5370-4090","observed_orcids":["https://orcid.org/0000-0002-5370-4090"]},"institutions":[{"id":"https://openalex.org/I4210124242","display_name":"Optum (United States)","ror":"https://ror.org/0370sjj75","country_code":"US","type":"company","lineage":["https://openalex.org/I4210124242"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lindsay G.S. Bengtson","raw_affiliation_strings":["Health Economics and Outcomes Research, Life Sciences, Optum, Eden Prairie, MN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Health Economics and Outcomes Research, Life Sciences, Optum, Eden Prairie, MN, USA","institution_ids":["https://openalex.org/I4210124242"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082266331","display_name":"Pamela L. Lutsey","orcid":"https://orcid.org/0000-0002-1572-1340","observed_orcids":["https://orcid.org/0000-0002-1572-1340"]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pamela L. Lutsey","raw_affiliation_strings":["Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, 1300 S 2nd St, Suite 300, Minneapolis, MN, 55454, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, 1300 S 2nd St, Suite 300, Minneapolis, MN, 55454, USA","institution_ids":["https://openalex.org/I130238516"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090746361","display_name":"Lin Y. Chen","orcid":"https://orcid.org/0000-0002-0700-814X","observed_orcids":["https://orcid.org/0000-0002-0700-814X"]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lin Y. Chen","raw_affiliation_strings":["Cardiac Arrhythmia Center, Cardiovascular Division, Department of Medicine, University of Minnesota Medical School, Minneapolis, MN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardiac Arrhythmia Center, Cardiovascular Division, Department of Medicine, University of Minnesota Medical School, Minneapolis, MN, USA","institution_ids":["https://openalex.org/I130238516"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030177580","display_name":"Richard F. MacLehose","orcid":"https://orcid.org/0000-0003-2041-3710","observed_orcids":["https://orcid.org/0000-0003-2041-3710"]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard F. MacLehose","raw_affiliation_strings":["Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, 1300 S 2nd St, Suite 300, Minneapolis, MN, 55454, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, 1300 S 2nd St, Suite 300, Minneapolis, MN, 55454, USA","institution_ids":["https://openalex.org/I130238516"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044494735","display_name":"Alanna M. Chamberlain","orcid":"https://orcid.org/0000-0003-1888-9584","observed_orcids":["https://orcid.org/0000-0003-1888-9584"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alanna M. Chamberlain","raw_affiliation_strings":["Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045547668","display_name":"Ian Rapson","orcid":"https://orcid.org/0000-0002-6707-0922","observed_orcids":["https://orcid.org/0000-0002-6707-0922"]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ian Rapson","raw_affiliation_strings":["Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, 1300 S 2nd St, Suite 300, Minneapolis, MN, 55454, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, 1300 S 2nd St, Suite 300, Minneapolis, MN, 55454, USA","institution_ids":["https://openalex.org/I130238516"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5004776448","display_name":"\u00c1lvaro Alonso","orcid":"https://orcid.org/0000-0002-2225-8323","observed_orcids":["https://orcid.org/0000-0002-2225-8323"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alvaro Alonso","raw_affiliation_strings":["Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA","institution_ids":["https://openalex.org/I150468666"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5071468650"],"corresponding_institution_ids":["https://openalex.org/I130238516"],"apc_list":{"value":3090,"currency":"USD","value_usd":3090},"apc_paid":{"value":3090,"currency":"USD","value_usd":3090},"fwci":6.116,"has_fulltext":true,"cited_by_count":63,"citation_normalized_percentile":{"value":0.9722663,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":100},"biblio":{"volume":"17","issue":"1","first_page":"238","last_page":"238"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10227","display_name":"Acute Ischemic Stroke Management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rivaroxaban","display_name":"rivaroxaban","score":0.9860000014305115},{"id":"https://openalex.org/keywords/warfarin","display_name":"warfarin","score":0.9779999852180481},{"id":"https://openalex.org/keywords/dabigatran","display_name":"dabigatran","score":1.0},{"id":"https://openalex.org/keywords/non-valvular-atrial-fibrillation","display_name":"non-valvular atrial fibrillation","score":0.9980000257492065},{"id":"https://openalex.org/keywords/oral-anticoagulants","display_name":"oral anticoagulants","score":0.9670000076293945},{"id":"https://openalex.org/keywords/ischemic-stroke","display_name":"ischemic stroke","score":0.7850000262260437},{"id":"https://openalex.org/keywords/intracranial-hemorrhage","display_name":"intracranial hemorrhage","score":0.9639999866485596},{"id":"https://openalex.org/keywords/gastrointestinal-bleeding","display_name":"gastrointestinal bleeding","score":0.9980000257492065},{"id":"https://openalex.org/keywords/myocardial-infarction","display_name":"myocardial infarction","score":0.996999979019165},{"id":"https://openalex.org/keywords/stroke-prevention","display_name":"stroke prevention","score":0.5109999775886536},{"id":"https://openalex.org/keywords/real-world-effectiveness","display_name":"real-world effectiveness","score":0.7490000128746033},{"id":"https://openalex.org/keywords/propensity-score-matching","display_name":"propensity score matching","score":0.7390000224113464},{"id":"https://openalex.org/keywords/marketscan-claims-data","display_name":"MarketScan claims data","score":0.6389999985694885},{"id":"https://openalex.org/keywords/comparative-effectiveness","display_name":"comparative effectiveness","score":0.4189999997615814}],"concepts":[{"id":"https://openalex.org/C2778661090","wikidata":"https://www.wikidata.org/wiki/Q420262","display_name":"Rivaroxaban","level":4,"score":0.979293704032898},{"id":"https://openalex.org/C2778810321","wikidata":"https://www.wikidata.org/wiki/Q419345","display_name":"Dabigatran","level":4,"score":0.954880952835083},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9233866930007935},{"id":"https://openalex.org/C2776301958","wikidata":"https://www.wikidata.org/wiki/Q407431","display_name":"Warfarin","level":3,"score":0.8182992935180664},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.7280953526496887},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.6609659194946289},{"id":"https://openalex.org/C2778205648","wikidata":"https://www.wikidata.org/wiki/Q215118","display_name":"Anticoagulant","level":2,"score":0.6259315013885498},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5946144461631775},{"id":"https://openalex.org/C2780645631","wikidata":"https://www.wikidata.org/wiki/Q671554","display_name":"Stroke (engine)","level":2,"score":0.589542806148529},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.39669886231422424},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.34839484095573425},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3234623670578003},{"id":"https://openalex.org/C78519656","wikidata":"https://www.wikidata.org/wiki/Q101333","display_name":"Mechanical engineering","level":1,"score":0.0},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000069552","descriptor_name":"Rivaroxaban","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000069552","descriptor_name":"Rivaroxaban","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000069604","descriptor_name":"Dabigatran","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000069604","descriptor_name":"Dabigatran","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000991","descriptor_name":"Antithrombins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000991","descriptor_name":"Antithrombins","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001281","descriptor_name":"Atrial Fibrillation","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D001281","descriptor_name":"Atrial Fibrillation","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D001281","descriptor_name":"Atrial Fibrillation","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D001281","descriptor_name":"Atrial Fibrillation","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001777","descriptor_name":"Blood Coagulation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006470","descriptor_name":"Hemorrhage","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014859","descriptor_name":"Warfarin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D014859","descriptor_name":"Warfarin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D015999","descriptor_name":"Multivariate Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016016","descriptor_name":"Proportional Hazards Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016017","descriptor_name":"Odds Ratio","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016208","descriptor_name":"Databases, Factual","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020521","descriptor_name":"Stroke","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D020521","descriptor_name":"Stroke","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D020521","descriptor_name":"Stroke","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D020521","descriptor_name":"Stroke","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D057186","descriptor_name":"Comparative Effectiveness Research","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065427","descriptor_name":"Factor Xa Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D065427","descriptor_name":"Factor Xa Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1186/s12872-017-0672-5","doi":"https://doi.org/10.1186/s12872-017-0672-5","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12872-017-0672-5","pdf_url":"https://bmccardiovascdisord.biomedcentral.com/track/pdf/10.1186/s12872-017-0672-5","source":{"id":"https://openalex.org/S206686666","display_name":"BMC Cardiovascular Disorders","issn_l":"1471-2261","issn":["1471-2261"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Cardiovascular Disorders","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:5585896","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5585896","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Cardiovasc Disord","raw_type":"Text"},{"id":"pmid:28874129","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28874129","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC cardiovascular disorders","raw_type":"Comparative Study"},{"id":"pmh:oai:doaj.org/article:c24f13afe22945c1bc60642713c93377","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/c24f13afe22945c1bc60642713c93377","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"BMC Cardiovascular Disorders, Vol 17, Iss 1, Pp 1-11 (2017)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1186/s12872-017-0672-5","doi":"https://doi.org/10.1186/s12872-017-0672-5","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12872-017-0672-5","pdf_url":"https://bmccardiovascdisord.biomedcentral.com/track/pdf/10.1186/s12872-017-0672-5","source":{"id":"https://openalex.org/S206686666","display_name":"BMC Cardiovascular Disorders","issn_l":"1471-2261","issn":["1471-2261"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Cardiovascular Disorders","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8100000023841858}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[{"id":"https://openalex.org/G1736345504","display_name":"Comparative Effectiveness of Oral Anticoagulants in Atrial Fibrillation","funder_award_id":"R01HL122200","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"},{"id":"https://openalex.org/G4560956716","display_name":null,"funder_award_id":"16EIA26410001","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"},{"id":"https://openalex.org/G5541543554","display_name":"Atrial fibrillation: epidemiology, prevention, and outcomes","funder_award_id":"16EIA26410001","funder_id":"https://openalex.org/F4320306230","funder_display_name":"American Heart Association"}],"funders":[{"id":"https://openalex.org/F4320306230","display_name":"American Heart Association","ror":"https://ror.org/013kjyp64"},{"id":"https://openalex.org/F4320337338","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2750718596.pdf","grobid_xml":"https://content.openalex.org/works/W2750718596.grobid-xml"},"referenced_works_count":41,"referenced_works":["https://openalex.org/W1504207271","https://openalex.org/W1539721984","https://openalex.org/W1917850483","https://openalex.org/W1967862917","https://openalex.org/W1986600951","https://openalex.org/W1998443206","https://openalex.org/W2012636090","https://openalex.org/W2021800013","https://openalex.org/W2027154314","https://openalex.org/W2031444608","https://openalex.org/W2045062962","https://openalex.org/W2046067187","https://openalex.org/W2056325986","https://openalex.org/W2061017329","https://openalex.org/W2061326496","https://openalex.org/W2074206824","https://openalex.org/W2076544060","https://openalex.org/W2076859422","https://openalex.org/W2079491969","https://openalex.org/W2097854437","https://openalex.org/W2107020336","https://openalex.org/W2107162481","https://openalex.org/W2111947972","https://openalex.org/W2114775432","https://openalex.org/W2120309474","https://openalex.org/W2121394112","https://openalex.org/W2130350934","https://openalex.org/W2136489990","https://openalex.org/W2137434301","https://openalex.org/W2140485936","https://openalex.org/W2159530110","https://openalex.org/W2162586165","https://openalex.org/W2170350621","https://openalex.org/W2196906371","https://openalex.org/W2209280676","https://openalex.org/W2261203049","https://openalex.org/W2314046741","https://openalex.org/W2404409120","https://openalex.org/W2520573665","https://openalex.org/W2529460814","https://openalex.org/W3026981879"],"related_works":["https://openalex.org/W2906621735","https://openalex.org/W2515183968","https://openalex.org/W2554174230","https://openalex.org/W2337949374","https://openalex.org/W2442037294","https://openalex.org/W2730131373","https://openalex.org/W2970045509","https://openalex.org/W2433454023","https://openalex.org/W4283159606","https://openalex.org/W2884828582"],"abstract_inverted_index":{"BACKGROUND:":[0],"Rivaroxaban":[1,57],"is":[2],"an":[3],"oral":[4,35,48],"anticoagulant":[5,49,71,110,253],"approved":[6],"in":[7,17,37,51,54,212,225,262],"the":[8,26,205,226,231],"US":[9],"for":[10],"prevention":[11],"of":[12,31,109,136,151,182,207,228,240,246,257],"stroke":[13,153],"and":[14,28,63,74,89,111,124,164,201,244],"systemic":[15],"embolism":[16],"patients":[18,46],"with":[19,61,133,204],"non-valvular":[20],"atrial":[21],"fibrillation":[22],"(NVAF).":[23],"We":[24,43],"determined":[25],"effectiveness":[27,243,256],"associated":[29],"risks":[30,245],"rivaroxaban":[32,118,140,177,200,213,247,258],"versus":[33,248,259],"other":[34],"anticoagulants":[36],"a":[38],"large":[39,237],"real-world":[40,238],"population.":[41],"METHODS:":[42],"selected":[44],"NVAF":[45,241],"initiating":[47],"use":[50],"2010-2014":[52],"enrolled":[53],"MarketScan":[55],"databases.":[56],"users":[58,65,119,127,187,214],"were":[59,93,102,195,221],"matched":[60,120],"warfarin":[62,123,172,186,249],"dabigatran":[64,126,202,260],"by":[66,251],"age,":[67],"sex,":[68],"enrolment":[69],"date,":[70,73],"initiation":[72],"high-dimensional":[75],"propensity":[76],"score.":[77],"Study":[78],"endpoints,":[79],"including":[80],"ischemic":[81,152],"stroke,":[82],"intracranial":[83],"bleeding":[84,184,210,264],"(ICB),":[85],"myocardial":[86],"infarction":[87],"(MI),":[88],"gastrointestinal":[90],"(GI)":[91],"bleeding,":[92],"identified":[94],"from":[95,146],"inpatient":[96],"diagnostic":[97],"codes.":[98],"Multivariable":[99],"Cox":[100],"models":[101],"used":[103],"to":[104,121],"assess":[105],"associations":[106],"between":[107],"type":[108],"outcomes.":[112],"RESULTS:":[113],"The":[114],"analysis":[115],"included":[116],"44,340":[117],"89,400":[122],"16,957":[125],"(38%":[128],"female,":[129],"mean":[130,137],"age":[131],"70)":[132],"12":[134],"months":[135],"follow-up.":[138],"Anticoagulant-na\u00efve":[139],"initiators,":[141,203],"but":[142],"not":[143],"those":[144],"switching":[145],"warfarin,":[147],"had":[148,179],"lower":[149],"risk":[150,181,211,227],"[hazard":[154],"ratio":[155],"(HR)":[156],"(95%":[157],"confidence":[158],"interval":[159],"(CI)):":[160],"0.75":[161],"(0.62,":[162],"0.91)]":[163],"ICB":[165],"[HR":[166,188,215],"(95%CI):":[167,189],"0.55,":[168],"(0.39,":[169],"0.78)]":[170],"than":[171,185],"users.":[173],"In":[174,235],"contrast,":[175],"anticoagulant-experienced":[176],"initiators":[178],"higher":[180,208],"GI":[183,209,263],"1.55":[190],"(1.32,":[191],"1.83)].":[192],"Endpoint":[193],"rates":[194],"similar":[196],"when":[197],"comparing":[198],"anticoagulant-na\u00efve":[199],"exception":[206],"(95%CI)":[216],"1.28":[217],"(1.06,":[218],"1.54)].":[219],"There":[220],"no":[222],"significant":[223],"differences":[224],"MI":[229],"among":[230],"comparison":[232],"groups.":[233],"CONCLUSION:":[234],"this":[236],"sample":[239],"patients,":[242],"differed":[250,261],"prior":[252],"status,":[254],"while":[255],"risk.":[265]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":13},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":15},{"year":2018,"cited_by_count":6},{"year":2016,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2017-09-15T00:00:00"}